Department of Drug Science and Technology

Preclinical research: delivery and targeting of anticancer drugs. Use of protein, polymeric inorganic and lipid carriers.

Preclinical research: Squalene derivatives to produce nanoparticles with therapeutical activity

Preclinical research: monoclonal antibody as delivery agent for new toxic molecules. Anticancer therapy

Preclinical researches. Cannabinoids as therapeutics for pain treatment. Endogenous proteins with antibacterial activity (lactoferrin derivatives)

Research in collaboration with industries  (AAA, Amersham-GE, Bracco, RBM-Merck Serono, GIPharma) based on the implementation of quality assurance in pharmaceutical research and production.

----------------------------------------------------------------------------------------------------